5-Isoxazolecarboxamide, N-[[4-(4-methyl-1-piperazinyl)phenyl]methyl]-

5-Isoxazolecarboxamide, N-[[4-(4-methyl-1-piperazinyl)phenyl]methyl]- Suppliers list
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: Shanghai Rechem science Co., Ltd.  
Tel: 021-31433387 15618786686
Email: sales@rechemscience.com
Company Name: Shanghai Chaolan Chemical Technology Center  
Tel: QQ:65489617 13301690235
Email: Sales@ATKchemical.com
Company Name: Beijing Solarbio Science & Tecnology Co., Ltd.  
Tel: 17801761073 18101056239
Email: 3193328036@qq.com

5-Isoxazolecarboxamide, N-[[4-(4-methyl-1-piperazinyl)phenyl]methyl]- manufacturers

  • SSAA09E2
  • SSAA09E2 pictures
  • $33.00
  • 2026-07-27
  • CAS:883944-52-3
  • Purity: 98.71%
  • Supply Ability: 10g
5-Isoxazolecarboxamide, N-[[4-(4-methyl-1-piperazinyl)phenyl]methyl]- Basic information
Product Name:5-Isoxazolecarboxamide, N-[[4-(4-methyl-1-piperazinyl)phenyl]methyl]-
Synonyms:5-Isoxazolecarboxamide, N-[[4-(4-methyl-1-piperazinyl)phenyl]methyl]-;SSAA09E2;domain,SARS-CoV,receptor,SSAA09E2,inhibit,SARS coronavirus,Inhibitor,spike,ACE2,binding,SSAA-09E2;N-(4-(4-Methylpiperazin-1-yl)benzyl)isoxazole-5-carboxamide;SSAA09E2, 10 mM in DMSO
CAS:883944-52-3
MF:C16H20N4O2
MW:300.36
EINECS:
Product Categories:
Mol File:883944-52-3.mol
5-Isoxazolecarboxamide, N-[[4-(4-methyl-1-piperazinyl)phenyl]methyl]- Structure
5-Isoxazolecarboxamide, N-[[4-(4-methyl-1-piperazinyl)phenyl]methyl]- Chemical Properties
Boiling point 571.2±50.0 °C(Predicted)
density 1.202±0.06 g/cm3(Predicted)
storage temp. 4°C, protect from light
solubility DMSO : 250 mg/mL (832.33 mM; Need ultrasonic)
pka13.60±0.46(Predicted)
form Solid
color White to light yellow
Safety Information
MSDS Information
5-Isoxazolecarboxamide, N-[[4-(4-methyl-1-piperazinyl)phenyl]methyl]- Usage And Synthesis
UsesSSAA09E2 is an inhibitor of SARS-CoV (Severe acute respiratory syndrome-Coronavirus) replication, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2) [1].
References[1] Bibi N, et al. Viroinformatics approach to explore the inhibitory mechanism of existing drugs repurposed to fight against COVID-19. Eur J Pharmacol. 2020;885:173496. DOI:10.1016/j.ejphar.2020.173496
5-Isoxazolecarboxamide, N-[[4-(4-methyl-1-piperazinyl)phenyl]methyl]- Preparation Products And Raw materials
Tag:5-Isoxazolecarboxamide, N-[[4-(4-methyl-1-piperazinyl)phenyl]methyl]-(883944-52-3) Related Product Information
Immunology/Inflammation Compound Library Anti-infection Compound Library